Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakub Hort

Showing results (141-150 of 185) with videos related to

Pageof 19
Sort By:
The Science of the Total Environment|July 5, 2022
Increased occurrence of Treponema spp. and double-species infections in patients with Alzheimer's diseaseMichal Nemergut, Tereza Batkova, Dana Vigasova, et al.
Drugs|June 20, 2024
Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's DiseaseJohn A Hey, Susan Abushakra, Kaj Blennow, et al.
Magma (New York, N.Y.)|June 29, 2020
Magnetic resonance markers of bilateral neuronal metabolic dysfunction in patients with unilateral internal carotid artery occlusionAlberto Malucelli, Antonin Skoch, Svapotluk Ostry, et al.
Neurology|September 25, 2020
Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementiasJozef Hanes, Andrej Kovac, Hlin Kvartsberg, et al.
The EPMA Journal|June 20, 2022
Digital biomarkers and sex impacts in Alzheimer's disease management - potential utility for innovative 3P medicine approachRobbert L Harms, Alberto Ferrari, Irene B Meier, et al.
Research Square|February 13, 2023
Sex differences in grey matter networks in dementia with Lewy bodiesAnnegret Habich, Javier Oltra, Christopher G Schwarz, et al.
Annals of Clinical and Translational Neurology|March 7, 2025
Relationship of cognitive decline with glucocerebrosidase activity and amyloid-beta 42 in DLB and PDMaria Camila Gonzalez, Linn Oftedal, Johannes Lange, et al.
Neuroimage. Clinical|July 17, 2020
The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodiesCarla Abdelnour, Daniel Ferreira, Ketil Oppedal, et al.
NPJ Parkinson'S Disease|April 16, 2026
Regional gene expression and brain atrophy in dementia with Lewy bodies: an imaging transcriptomics studyAnnegret Habich, Janna M Baumann, Christopher G Schwarz, et al.
Alzheimer'S Research & Therapy|May 24, 2025
Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADCKristian S Frederiksen, Mercé Boada, Bruno Dubois, et al.
Pageof 19

Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
The Science of the Total Environment|July 5, 2022
Increased occurrence of Treponema spp. and double-species infections in patients with Alzheimer's diseaseMichal Nemergut, Tereza Batkova, Dana Vigasova, et al.
Drugs|June 20, 2024
Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's DiseaseJohn A Hey, Susan Abushakra, Kaj Blennow, et al.
Magma (New York, N.Y.)|June 29, 2020
Magnetic resonance markers of bilateral neuronal metabolic dysfunction in patients with unilateral internal carotid artery occlusionAlberto Malucelli, Antonin Skoch, Svapotluk Ostry, et al.
Neurology|September 25, 2020
Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementiasJozef Hanes, Andrej Kovac, Hlin Kvartsberg, et al.
The EPMA Journal|June 20, 2022
Digital biomarkers and sex impacts in Alzheimer's disease management - potential utility for innovative 3P medicine approachRobbert L Harms, Alberto Ferrari, Irene B Meier, et al.
Research Square|February 13, 2023
Sex differences in grey matter networks in dementia with Lewy bodiesAnnegret Habich, Javier Oltra, Christopher G Schwarz, et al.
Annals of Clinical and Translational Neurology|March 7, 2025
Relationship of cognitive decline with glucocerebrosidase activity and amyloid-beta 42 in DLB and PDMaria Camila Gonzalez, Linn Oftedal, Johannes Lange, et al.
Neuroimage. Clinical|July 17, 2020
The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodiesCarla Abdelnour, Daniel Ferreira, Ketil Oppedal, et al.
NPJ Parkinson'S Disease|April 16, 2026
Regional gene expression and brain atrophy in dementia with Lewy bodies: an imaging transcriptomics studyAnnegret Habich, Janna M Baumann, Christopher G Schwarz, et al.
Alzheimer'S Research & Therapy|May 24, 2025
Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADCKristian S Frederiksen, Mercé Boada, Bruno Dubois, et al.
Pageof 19